Daesung Microbiological Labs. Co. Ltd (036480) — Capital Reinvestment Ratio
Daesung Microbiological Labs. Co. Ltd (036480) has a Capital Reinvestment Ratio of 0.01x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩972.26 Million) in capital expenditures (₩5.66 Million). Check 036480 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Daesung Microbiological Labs. Co. Ltd Capital Reinvestment Ratio (2012–2025)
This chart tracks Daesung Microbiological Labs. Co. Ltd's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see Daesung Microbiological Labs. Co. Ltd operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Daesung Microbiological Labs. Co. Ltd (2012–2025)
Year-by-year Capital Reinvestment Ratio for Daesung Microbiological Labs. Co. Ltd from 2012 to 2025. See Daesung Microbiological Labs. Co. Ltd (036480) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | ₩1.41 Billion | ₩358.09 Million | ▼ -32.9% |
| 2024 | 0.38x | ₩2.10 Billion | ₩795.87 Million | ▼ -81.1% |
| 2022 | 2.00x | ₩1.16 Billion | ₩2.32 Billion | ▲ +48.7% |
| 2021 | 1.35x | ₩2.20 Billion | ₩2.97 Billion | ▼ -68.9% |
| 2020 | 4.33x | ₩3.24 Billion | ₩14.01 Billion | ▼ -12.4% |
| 2019 | 4.94x | ₩2.32 Billion | ₩11.44 Billion | ▲ +3558.7% |
| 2018 | 0.14x | ₩3.14 Billion | ₩423.50 Million | ▼ -79.9% |
| 2017 | 0.67x | ₩1.68 Billion | ₩1.13 Billion | ▲ +149.5% |
| 2016 | 0.27x | ₩3.52 Billion | ₩947.87 Million | ▲ +135.8% |
| 2015 | 0.11x | ₩7.66 Billion | ₩874.96 Million | ▼ -47.2% |
| 2014 | 0.22x | ₩3.83 Billion | ₩828.54 Million | ▼ -85.8% |
| 2013 | 1.52x | ₩1.89 Billion | ₩2.88 Billion | ▲ +1599.8% |
| 2012 | 0.09x | ₩2.33 Billion | ₩209.00 Million | — |